1. Development and Application of Participatory Action Oriented Training(PAOT) for Improvement of Agricultural Working Environment in Korea.
J S KIM ; K H WOO ; Y S MIN ; B K KIM ; K S CHOI ; K S PARK
Journal of Agricultural Medicine & Community Health 2010;35(4):417-427
OBJECTIVES: This study was conducted to develop a Korean version of the Participatory Action Oriented Training (PAOT) program and training materials for improvement of agricultural working environments. METHODS: The PAOT manual and checklist were developed on the basis of the original English version of the training materials, a questionnaire survey of agricultural health and safety professionals, and a brainstorming conference. Good example pictures were collected through visits to agricultural workers' houses, and an easily understandable picture was drawn by an animation specialist. A PAOT action manual and five types of action checklists were developed for use in different agricultural environments. Each action checklist contained six categories and 38 items of agricultural health and safety principles; the six categories were material storage and handling, work stations and tools, machine safety, physical environment, working schedule and organization, and basic health and safety management. Incorporating these training materials, a one-day Korean PAOT program was developed. RESULTS: Among 307 candidate agricultural workers from four rural Korean villages, 94 workers (59 males, 35 females) participated in a PAOT from July 2007 to Oct 2008. The PAOT program was successful and the mean self-estimated satisfaction score of the participants was greater than 90%. CONCLUSIONS: A Korean PAOT program and training materials were successfully developed and applied to Korean agricultural workers. Although more studies are needed, it is expected that PAOT will greatly contribute to the improvement of agricultural working conditions and health and safety through the use of agricultural workers' self initiatives.
Appointments and Schedules
;
Checklist
;
Farmers
;
Handling (Psychology)
;
Humans
;
Korea
;
Male
;
Safety Management
;
Specialization
;
Surveys and Questionnaires
2.In vitro study on realgar induced apoptosis of all-trans acid resistant acute promeylocytic leukemia cell line (MR2).
Si-yu CHEN ; Shan-xi LIU ; Xin-min LI
China Journal of Chinese Materia Medica 2002;27(3):211-215
OBJECTIVETo acquire a deep understanding of the possible mechanisms of realgar in the treatment of acute promyelocytic leukemia (APL).
METHODAll-trans retinoic acid (ATRA) resistant APL cell line MR2 was used as in vitro model. The effect of realgar on MR2 cell was observed by watching cell viability, cell growth, and by using Methy thiazolyl tetrazolium (MTT) assay, cell morphology, DNA gel electrophoresis and flow cytometry assay.
RESULTThe viability and growth of MR2 cell were inhibited after the treatment, to some extent, in a dose and time dependent manner. After being treated with realgar, MR2 cell presented morphologically some features of apoptotic cells such as intact cell membrane, chromatin condensation and nuclear fragmentation, and apoptotic body could be found by electron microscopy as well. Sub-G1 cells were observed by flow cytometry, as well as Annexin V FITC+/PI-cells. DNA ladder could be found by DNA gel electrophoresis.
CONCLUSIONRealgar can induce apoptosis of ATRA resistant APL cell line MR2, Which shows the therapeutic effect of realgar on APL may be different from that of ATRA.
Antineoplastic Agents ; pharmacology ; Apoptosis ; drug effects ; Arsenicals ; pharmacology ; Cell Division ; drug effects ; Cell Survival ; drug effects ; Drug Resistance, Neoplasm ; Humans ; Leukemia, Promyelocytic, Acute ; pathology ; Materia Medica ; pharmacology ; Sulfides ; pharmacology ; Tretinoin ; pharmacology ; Tumor Cells, Cultured
3.Exercise Across the Phases of Cancer Survivorship: A Narrative Review
Ki-Yong AN ; Jihee MIN ; Dong Hoon LEE ; Dong-Woo KANG ; Kerry S. COURNEYA ; Justin Y. JEON
Yonsei Medical Journal 2024;65(6):315-323
Exercise has long been recognized as an important component of treatment for various diseases. However, the benefits and risks of exercise interventions must be carefully evaluated to ensure the former outweighs the latter. As cancer patients undergo diverse treatment modalities with distinct objectives, a systematic approach partitioning the cancer journey into distinct phases is necessary to inform tailored exercise prescriptions. This narrative review summarizes exercise benefits and mechanisms for cancer patients and survivors across four distinct survivorship periods—before surgery, after surgery and before adjuvant treatment, during nonsurgical treatment (adjuvant and neoadjuvant), and during extended survival. In summary, exercise reduces the risks of complications and declines in physical functioning while improving fatigue, quality of life, and the ability to manage treatment effects. Although additional research is warranted, existing evidence is sufficient to integrate exercise into clinical oncology practice and cancer survivorship programs.
4.Three New Monotypic Genera of the Caloplacoid Lichens (Teloschistaceae, Lichen-Forming Ascomycetes).
Sergii Y KONDRATYUK ; Laszlo LOKOS ; Jung A KIM ; Anna S KONDRATIUK ; Min Hye JEONG ; Seol Hwa JANG ; Soon Ok OH ; Jae Seoun HUR
Mycobiology 2015;43(3):195-202
Three monophyletic branches are strongly supported in a phylogenetic analysis of the Teloschistaceae based on combined data sets of internal transcribed spacer and large subunit nrDNA and 12S small subunit mtDNA sequences. These are described as new monotypic genera: Jasonhuria S. Y. Kondr., L. Lokos et S. -O. Oh, Loekoesia S. Y. Kondr., S. -O. Oh et J. -S. Hur and Olegblumia S. Y. Kondr., L. Lokos et J. -S. Hur. Three new combinations for the type species of these genera are proposed.
Dataset
;
DNA, Mitochondrial
;
Lichens*
5.A Clinical Study of Topical Minoxidil Therapy in Alopecia: Multicenter Trials.
Min Geol LEE ; Moon Soo YOON ; Jung Bock LEE ; Byung In RO ; Hyung Ok KIM ; Kyung Jae CHUNG ; Choong Rim HAW ; Kyu Suk LEE ; S N KIM ; S J SON ; J A KIM ; H J KIM ; H I KOOK ; H S SUNG ; Y P KIM ; C W IHM ; J K PARK ; K J KIM ; J H KIM
Korean Journal of Dermatology 1986;24(2):181-189
No abstract available.
Alopecia*
;
Minoxidil*
6.Neonatal Statistics of Korea in 1996: Collective Results of Live - Births , Neonatal Mortality , and Incidence of Dischage Against Medical Advice at 64 Hospitals.
Chong Woo BAE ; Min Hee KIM ; Chung Sik CHUN ; Chul LEE ; S J MOON ; Byoung Hoon YOO ; Baek Keun LIM ; Sang Geel LEE ; Young Youn CHOI ; Sang Hyun BYUN ; Ahn Hong CHOI ; S Y PI ; Dong Gwan HAN ; Chong Ku YUN
Journal of the Korean Society of Neonatology 1997;4(2):153-169
PURPOSE: To evaluate the nation-wide results of statistics related to the neonatal period of 1996, we collected data of a total of 64 hospitals in Korea (42 university hos- pitals and 22 general hospitals). METHODS: We obtained the results of 129,175 inboms and 9,379 outborns, and analyzed the statistics of live-births, ig, distribution of live-births by gestational age and birth weight, incidence of pre-term infants and low birth weight infants (LBWI), neonatal mortality, and incidence of discharge against medical advice (DAMA). RESULTS: According to birth weight, incidence of LBWI, normal birth weight, infant and high birth weight infants was 3.6%, 86.6% and 9.8%, respectively in the case of inborn group. But incidence of LBWI was higher in outborn group as compared with the inbom group. According to gestational age, incidence of preterm, term, and post-term was 11.1%, 87.1Yo and 1.8% respectively in the inbom group. The incidence of preterm in outborn group was higher than that of inborn group, because of the influnce of transpor- tation of high risk neonates to 2nd or 3rd levels of neonatal intensive care units (NICU). Overall neonatal mortality per 1,000 live-births was 9.3 in the inborn group amd 37.6% in the outborn group. These data revealed a high neonatal mortality, because the numbers of DAMA cases was also included. The incidence of DAMA was 0.44% and 1.15% in inborn and outborn groups, respectively. The percentage of the DAMA among the numbers of neonatal mortality was 47.2-48.8M in the inborn group. CONCLUSIONS: We obtained the statistics related to live-birth, incidence of prematurity and LBWI, neonatal mortality, and incidence of DAMA in Korea. The data revealed high levels of neonatal mortality (which included the sum of neonatal death and the number of DAMA) and incidence of DAMA in Korea at present. To achieve a low-level of neonatal mortality, more efforts to decrease the incidence of DAMA are needed. Also, a greater facility for NICU and a stronger support system from a nation-wide govemment policy and system of insurance are seen to be necessary.
Birth Weight
;
Gestational Age
;
Humans
;
Incidence*
;
Infant
;
Infant Mortality*
;
Infant, Low Birth Weight
;
Infant, Newborn
;
Insurance
;
Intensive Care Units, Neonatal
;
Korea*
;
Parturition*
7.National surgical antibiotic prophylaxis guideline in Singapore.
Wei Teng Gladys CHUNG ; Humaira SHAFI ; Jonathan SEAH ; Parthasarathy PURNIMA ; Taweechai PATUN ; Kai Qian KAM ; Valerie Xue Fen SEAH ; Rina Yue Ling ONG ; Li LIN ; Robin Sing Meng CHOO ; Pushpalatha LINGEGOWDA ; Cheryl Li Ling LIM ; Jasmine Shimin CHUNG ; Nathalie Grace S Y CHUA ; Tau Hong LEE ; Min Yi YAP ; Tat Ming NG ; Jyoti SOMANI
Annals of the Academy of Medicine, Singapore 2022;51(11):695-711
INTRODUCTION:
Institutional surgical antibiotic prophylaxis (SAP) guidelines are in place at all public hospitals in Singapore, but variations exist and adherence to guidelines is not tracked consistently. A national point prevalence survey carried out in 2020 showed that about 60% of surgical prophylactic antibiotics were administered for more than 24 hours. This guideline aims to align best practices nationally and provides a framework for audit and surveillance.
METHOD:
This guideline was developed by the National Antimicrobial Stewardship Expert Panel's National Surgical Antibiotic Prophylaxis Guideline Development Workgroup Panel, which comprises infectious diseases physicians, pharmacists, surgeons and anaesthesiologists. The Workgroup adopted the ADAPTE methodology framework with modifications for the development of the guideline. The recommended duration of antibiotic prophylaxis was graded according to the strength of consolidated evidence based on the scoring system of the Singapore Ministry of Health Clinical Practice Guidelines.
RESULTS:
This National SAP Guideline provides evidence-based recommendations for the rational use of antibiotic prophylaxis. These include recommended agents, dose, timing and duration for patients undergoing common surgeries based on surgical disciplines. The Workgroup also provides antibiotic recommendations for special patient population groups (such as patients with β-lactam allergy and patients colonised with methicillin-resistant Staphylococcus aureus), as well as for monitoring and surveillance of SAP.
CONCLUSION
This evidence-based National SAP Guideline for hospitals in Singapore aims to align practices and optimise the use of antibiotics for surgical prophylaxis for the prevention of surgical site infections while reducing adverse events from prolonged durations of SAP.
Humans
;
Antibiotic Prophylaxis
;
Anti-Bacterial Agents/therapeutic use*
;
Methicillin-Resistant Staphylococcus aureus
;
Singapore
;
Surgeons
;
Hospitals, Public
8.BNT162B2 COVID-19 mRNA vaccination did not promote substantial anti-syncytin-1 antibody production nor mRNA transfer to breast milk in an exploratory pilot study.
Citra N Z MATTAR ; Winston KOH ; Yiqi SEOW ; Shawn HOON ; Aparna VENKATESH ; Pradip DASHRAATH ; Li Min LIM ; Judith ONG ; Rachel LEE ; Nuryanti JOHANA ; Julie S L YEO ; David CHONG ; Lay Kok TAN ; Jerry K Y CHAN ; Mahesh CHOOLANI ; Paul Anantharajah TAMBYAH
Annals of the Academy of Medicine, Singapore 2022;51(5):309-312
9.2019 Seoul Consensus on Esophageal Achalasia Guidelines
Hye-Kyung JUNG ; Su Jin HONG ; Oh Young LEE ; John PANDOLFINO ; Hyojin PARK ; Hiroto MIWA ; Uday C GHOSHAL ; Sanjiv MAHADEVA ; Tadayuki OSHIMA ; Minhu CHEN ; Andrew S B CHUA ; Yu Kyung CHO ; Tae Hee LEE ; Yang Won MIN ; Chan Hyuk PARK ; Joong Goo KWON ; Moo In PARK ; Kyoungwon JUNG ; Jong Kyu PARK ; Kee Wook JUNG ; Hyun Chul LIM ; Da Hyun JUNG ; Do Hoon KIM ; Chul-Hyun LIM ; Hee Seok MOON ; Jung Ho PARK ; Suck Chei CHOI ; Hidekazu SUZUKI ; Tanisa PATCHARATRAKUL ; Justin C Y WU ; Kwang Jae LEE ; Shinwa TANAKA ; Kewin T H SIAH ; Kyung Sik PARK ; Sung Eun KIM ;
Journal of Neurogastroenterology and Motility 2020;26(2):180-203
Esophageal achalasia is a primary motility disorder characterized by insufficient lower esophageal sphincter relaxation and loss of esophageal peristalsis. Achalasia is a chronic disease that causes progressive irreversible loss of esophageal motor function. The recent development of high-resolution manometry has facilitated the diagnosis of achalasia, and determining the achalasia subtypes based on high-resolution manometry can be important when deciding on treatment methods. Peroral endoscopic myotomy is less invasive than surgery with comparable efficacy. The present guidelines (the “2019 Seoul Consensus on Esophageal Achalasia Guidelines”) were developed based on evidence-based medicine; the Asian Neurogastroenterology and Motility Association and Korean Society of Neurogastroenterology and Motility served as the operating and development committees, respectively. The development of the guidelines began in June 2018, and a draft consensus based on the Delphi process was achieved in April 2019. The guidelines consist of 18 recommendations: 2 pertaining to the definition and epidemiology of achalasia, 6 pertaining to diagnoses, and 10 pertaining to treatments. The endoscopic treatment section is based on the latest evidence from meta-analyses. Clinicians (including gastroenterologists, upper gastrointestinal tract surgeons, general physicians, nurses, and other hospital workers) and patients could use these guidelines to make an informed decision on the management of achalasia.
10.Ministry of Health Clinical Practice Guidelines: Hypertension.
Jam Chin TAY ; Ashish Anil SULE ; E K CHEW ; Jeannie S TEY ; Titus LAU ; Simon LEE ; Sze Haur LEE ; Choon Kit LEONG ; Soo Teik LIM ; Lip Ping LOW ; Vernon Min Sen OH ; K Y PHOON ; Kian Wee Kenneth TAN ; Akira WU ; Loo See YEO
Singapore medical journal 2018;59(1):17-27
The Ministry of Health (MOH) has updated the clinical practice guidelines on hypertension to provide doctors and patients in Singapore with evidence-based treatment for hypertension. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH clinical practice guidelines on hypertension, for the information of SMJ readers. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: http://www.moh.gov.sg/content/moh_web/healthprofessionalsportal/doctors/guidelines/cpg_medical.html. The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.
Antihypertensive Agents
;
therapeutic use
;
Blood Pressure
;
Evidence-Based Medicine
;
Health Promotion
;
Humans
;
Hypertension
;
diagnosis
;
therapy
;
Life Style
;
Risk Factors
;
Singapore